Back
The Allstate Corp. Vs. Axsome Therapeutics, Inc. Industry Stock Comparison
Buy
61
ALL
The Allstate Corp.
Last Price:
$209.21
Seasonality Move:
1.7%
Buy
61
AXSM
Axsome Therapeutics, Inc.
Last Price:
$153.81
Seasonality Move:
41.16%
Buy
61
The Allstate Corp. (ALL)
is a Buy
Is The Allstate Corp. a Buy, Sell or Hold?
-
The current The Allstate Corp. [ALL] share price is $209.05. The Score for ALL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
ALL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Axsome Therapeutics, Inc. (AXSM)
is a Buy
Is Axsome Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Axsome Therapeutics, Inc. [AXSM] share price is $153.64. The Score for AXSM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
AXSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALL Stock Price Chart
What is The Allstate Corp.'s stock price today?
-
The The Allstate Corp. share price today is $209.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALL is experiencing selling pressure, which indicates risk of future bearish movement.
AXSM Stock Price Chart
What is Axsome Therapeutics, Inc.'s stock price today?
-
The Axsome Therapeutics, Inc. share price today is $153.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
ALL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.65 | Buy |
| Relative Strength Index (14 RSI): | 54.23 | Buy |
| Chaikin Money Flow: | -279722 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (204.42 - 212.26) | Buy |
| Bollinger Bands (100): | (198.52 - 211.22) | Buy |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.01 | Buy |
| Relative Strength Index (14 RSI): | 62.53 | Buy |
| Chaikin Money Flow: | -127710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (145.83 - 151.93) | Buy |
| Bollinger Bands (100): | (115.16 - 143.94) | Buy |
ALL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 208.42 | Buy |
| 20-day SMA: | 207.37 | Buy |
| 50-day SMA: | 203.47 | Buy |
| 200-day SMA: | 202.22 | Buy |
| 8-day EMA: | 207.92 | Buy |
| 20-day EMA: | 207.32 | Buy |
| 50-day EMA: | 205.87 | Buy |
| 200-day EMA: | 200.74 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 150.41 | Buy |
| 20-day SMA: | 149.05 | Buy |
| 50-day SMA: | 141.92 | Buy |
| 200-day SMA: | 118.97 | Buy |
| 8-day EMA: | 151.5 | Buy |
| 20-day EMA: | 148.84 | Buy |
| 50-day EMA: | 141.92 | Buy |
| 200-day EMA: | 122.29 | Buy |
The Allstate Corp. Earnings Growth & ALL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.20 per share, and a decrease next year of $4.97 per share.
Axsome Therapeutics, Inc. Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.39 per share, and an increase next year of $4.12 per share.
The Allstate Corp. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||